GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BIOGY) » Definitions » Equity-to-Asset
中文

BioGaia AB (BioGaia AB) Equity-to-Asset : 0.87 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BioGaia AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $197.9 Mil. BioGaia AB's Total Assets for the quarter that ended in Dec. 2023 was $227.5 Mil. Therefore, BioGaia AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.87.

The historical rank and industry rank for BioGaia AB's Equity-to-Asset or its related term are showing as below:

BIOGY' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.76   Med: 0.84   Max: 0.91
Current: 0.87

During the past 13 years, the highest Equity to Asset Ratio of BioGaia AB was 0.91. The lowest was 0.76. And the median was 0.84.

BIOGY's Equity-to-Asset is ranked better than
91.08% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BIOGY: 0.87

BioGaia AB Equity-to-Asset Historical Data

The historical data trend for BioGaia AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Equity-to-Asset Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.91 0.88 0.89 0.87

BioGaia AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.90 0.87 0.86 0.87

Competitive Comparison of BioGaia AB's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Equity-to-Asset falls into.



BioGaia AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BioGaia AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=197.935/227.46
=0.87

BioGaia AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=197.935/227.46
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioGaia AB  (OTCPK:BIOGY) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


BioGaia AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB (BioGaia AB) Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.